Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
Maravai LifeSciences' Cygnus & TriLink Unveil AccuRes DNA Kits
10:25am, Thursday, 29'th Aug 2024
MRVI's Cygnus and TriLink introduce AccuRes kits, setting a new standard in host cell DNA quantification with unmatched sensitivity and specificity.
Exclusive: Repligen in bid for reagent vendor Maravai, sources say
11:46am, Friday, 16'th Aug 2024
Repligen , a provider of drug manufacturing equipment, has approached Maravai LifeSciences Holdings , a vaccine capping reagent vendor that has a market value of $2.2 billion, with an acquisition offe
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
08:05am, Monday, 12'th Aug 2024
SAN DIEGO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to p
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2024 Earnings Call Transcript
06:19am, Thursday, 08'th Aug 2024
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q2 2024 Results Conference Call August 7, 2024 5:00 PM ET Company Participants Deborah Hart - Head, Investor Relations Trey Martin - Chief Executive
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, August 7, 2024
08:00am, Wednesday, 10'th Jul 2024
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
Maravai Lifesciences Releases 2023 Environmental, Social and Governance (ESG) Report
04:00pm, Tuesday, 02'nd Jul 2024
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth.
- Project Results in over 70% Reduction in Linea RNAP Manufacturing Cost to Yield a Material Improvement in Linea IVT Platform Profitability - - Applied DNA Secures Commercial Linea RNAP Quantity Suff
Maravai (MRVI) Advances in RNA Research With New Collaboration
12:56pm, Friday, 17'th May 2024
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
04:05pm, Thursday, 09'th May 2024
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to pa
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings Call Transcript
08:59pm, Wednesday, 08'th May 2024
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q1 2024 Earnings Conference Call May 8, 2024 5:00 PM ET Company Participants Debbie Hart - Head, Investor Relations Trey Martin - Chief Executive Off
Maravai LifeSciences Reports First Quarter 2024 Financial Results
04:05pm, Wednesday, 08'th May 2024
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
07:31am, Tuesday, 30'th Apr 2024
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology.
TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production
07:36am, Thursday, 18'th Apr 2024
SAN DIEGO--(BUSINESS WIRE)--TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production.
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024
04:05pm, Wednesday, 10'th Apr 2024
SAN DIEGO, April 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
04:15pm, Tuesday, 12'th Mar 2024
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to
